Literature DB >> 31772797

Corrigendum to "Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience".

Vidhya Karivedu1, Ihab Eldessouki1, Zelia Correa2, Ahmad Taftaf1, Zheng Zhu3, Abouelmagd Makramalla4, Nagla Abdel Karim5.   

Abstract

[This corrects the article DOI: 10.1155/2019/3560640.].
Copyright © 2019 Vidhya Karivedu et al.

Entities:  

Year:  2019        PMID： 31772797      PMCID： PMC6854979          DOI： 10.1155/2019/3868790

Source DB:  PubMed          Journal:  Case Rep Oncol Med


In the article titled “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience” [1], Dr. Zelia Correa was missing from the authors' list. Dr. Zelia Correa commented on the article and referred the patient population in the study. The corrected authors' list and affiliations are shown above.
  1 in total

1.  Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience.

Authors:  Vidhya Karivedu; Ihab Eldessouki; Ahmad Taftaf; Zheng Zhu; Abouelmagd Makramalla; Nagla Abdel Karim
Journal:  Case Rep Oncol Med       Date:  2019-04-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.